# GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE
> **ANDA213203** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2020-03-25
## Drug
- **FDA Application Number:** ANDA213203
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE
- **Generic name:** GUAIFENESIN AND PSEUDOEPHEDRINE HCL
- **Active ingredients:** GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** AUROBINDO PHARMA LTD
- **Manufacturer:** Amerisource Bergen
- **First approval:** 2020-03-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213203)
---
*AI Analytics · CC0 1.0*